Literature DB >> 11235429

Pain: neuroanatomy, chemical mediators, and clinical implications.

J M McHugh1, W B McHugh.   

Abstract

Most pain information begins at simple, naked nerve endings called nociceptors that form a functional pain unit with nearby tissue capillaries and mast cells. Tissue injury causes these nerve terminals to depolarize, an event that is propagated along the entire afferent fiber eventuating in sensory impulses reaching the spinal cord. This firing of primary afferent fibers at the site of tissue injury causes axonal release of vesicles containing neuropeptides such as substance P, which acts in an autocrine and paracrine manner to sensitize the nociceptor and increase its rate of firing. Cellular damage and inflammation increase concentrations of other chemical mediators such as histamine, bradykinin, and prostaglandins in the area surrounding functional pain units. These additional mediators act synergistically to augment the transmission of nociceptive impulses along sensory afferent fibers. Primary fibers travel from the periphery to the dorsal horn where they synapse on secondary neurons and interneurons. When activated, interneurons exert inhibitory influences on further pain signal trafficking. Efferent supraspinal influences, in turn, determine the activity of interneurons by releasing a variety of neurotransmitter substances, thus resulting in a high degree of modulation of nociception within the dorsal horn. Events occurring in the periphery and in the dorsal horn can cause a dissociation of pain perception from the presence or degree of actual tissue injury. These phenomena involve many chemical mediators and receptor systems, and can increase pain experience qualitatively, quantitatively, temporally, and spatially. The complexity and plasticity of the nociceptive system can make clinical management of pain difficult. Undestanding the structure and chemical signals associated with this system can improve the use of existing analgesics and provide targets for development of newer and more specific pain-fighting drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11235429     DOI: 10.1097/00044067-200005000-00003

Source DB:  PubMed          Journal:  AACN Clin Issues        ISSN: 1079-0713


  14 in total

1.  The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats.

Authors:  Syed Uzair Ali Shah; Nadeem Ashraf; Zahid H Soomro; Muhammad Raza Shah; Nurul Kabir; Shabana Usman Simjee
Journal:  Inflamm Res       Date:  2012-04-27       Impact factor: 4.575

2.  N-(2-Hydroxyphenyl)acetamide: a Novel Suppressor of RANK/RANKL Pathway in Collagen-Induced Arthritis Model in Rats.

Authors:  Anum Gul; Bimal Kunwar; Maryam Mazhar; Kahkashan Perveen; Shabana U Simjee
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

3.  Measurement of substance P and met-enkephalin in the serum of violent death victims.

Authors:  Lawrence Quarino; Robert C Shaler
Journal:  Forensic Sci Med Pathol       Date:  2006-12       Impact factor: 2.007

Review 4.  Implication of Hypothalamus in Alleviating Spinal Cord Injury-Induced Neuropathic Pain.

Authors:  Andrew D Crowell; Kevin King; Annika Deitermann; Gurwattan S Miranpuri; Daniel K Resnick
Journal:  Ann Neurosci       Date:  2016-09-09

5.  Bupivacaine effectively relieves inflammation-induced pain by suppressing activation of the NF-κB signalling pathway and inhibiting the activation of spinal microglia and astrocytes.

Authors:  Jingliang Zhang; Xinlian Deng
Journal:  Exp Ther Med       Date:  2017-01-18       Impact factor: 2.447

Review 6.  The analgesic potential of glycosides derived from medicinal plants.

Authors:  Haroon Khan; Aini Pervaiz; Sebastiano Intagliata; Niranjan Das; Kalyan C Nagulapalli Venkata; Atanas G Atanasov; Agnieszka Najda; Seyed Mohammad Nabavi; Dongdong Wang; Valeria Pittalà; Anupam Bishayee
Journal:  Daru       Date:  2020-02-14       Impact factor: 3.117

7.  Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.

Authors:  David M Marks; Manan J Shah; Ashwin A Patkar; Prakash S Masand; Geun-Young Park; Chi-Un Pae
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 8.  Pain Perception and Management: Where do We Stand?

Authors:  Bilal Afridi; Haroon Khan; Esra K Akkol; Michael Aschner
Journal:  Curr Mol Pharmacol       Date:  2021       Impact factor: 3.339

9.  Genome-wide analysis of pain-, nerve- and neurotrophin -related gene expression in the degenerating human annulus.

Authors:  Helen E Gruber; Gretchen L Hoelscher; Jane A Ingram; Edward N Hanley
Journal:  Mol Pain       Date:  2012-09-10       Impact factor: 3.395

10.  The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis.

Authors:  Syed Uzair A Shah; Huma Jawed; Shahid I Awan; Shazia Anjum; Shabana U Simjee
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.